| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 19.11.25 | Primerdesign Launches Exsig Mag RapidBead Pro Extraction Kit | ||
| 19.11.25 | EC Approves Subcutaneous Administration of Keytruda | ||
| 19.11.25 | AGC Biologics, Repair Biotechnologies Partner to Develop & Manufacture mRNA Therapeutic | ||
| 18.11.25 | Johnson & Johnson 3Q Results | ||
| 18.11.25 | Agenus Taps Dr. José Iglesias as Chief Medical Affairs Officer | ||
| 18.11.25 | Halozyme Therapeutics Acquires Elektrofi for $750M | ||
| 18.11.25 | BioDuro Launches Peptide Business Unit | ||
| 18.11.25 | Thermo Fisher Scientific Opens Advanced Therapies Collaboration Center in Philadelphia | ||
| 18.11.25 | Debiopharm Launches IDEAL Japan Initiative | ||
| 18.11.25 | European Commission Approves Remsima IV Liquid Formulation | ||
| 17.11.25 | Solve Therapeutics Raises $120M in Latest Funding Round | ||
| 17.11.25 | Andelyn Biosciences Signs Licensing Agreement with Solid Biosciences | ||
| 17.11.25 | Merus, Halozyme Partner to Develop Subcutaneous Formulation of Petosemtamab | ||
| 17.11.25 | AdvanCell Appoints Philina Lee as CEO | ||
| 17.11.25 | Polpharma Biologics Launches Tyruko in the U.S. | ||
| 17.11.25 | Sonoma Biotherapeutics Names Stephen Dilly as CEO | ||
| 14.11.25 | Merck 3Q Results | ||
| 14.11.25 | Pfizer 3Q Results | ||
| 14.11.25 | Abbvie 3Q Results | ||
| 14.11.25 | TandemAI Secures $22M Series A Extension | ||
| 14.11.25 | Merck to Acquire Cidara Therapeutics | ||
| 13.11.25 | HHS Appoints Director of Center for Drug Evaluation and Research | ||
| 13.11.25 | Cytovance Biologics Celebrates 20 Years in Oklahoma City | ||
| 13.11.25 | Neurvati Neurosciences Appoints New Chief Commercial Officer | ||
| 13.11.25 | Domain Therapeutics Names Jean-Marie Cuillerot as Chief Medical Officer |